Literature DB >> 4281316

Mycosis fungoides--a disease of antigen persistence.

R S Tan, C M Butterworth, H McLaughlin, S Malka, P D Samman.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4281316     DOI: 10.1111/j.1365-2133.1974.tb12449.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


× No keyword cloud information.
  31 in total

1.  Further similarities between Sézary syndrome and mycosis fungoides.

Authors:  M Hagedorn; W Born; J Kunze; U Riede
Journal:  Arch Dermatol Res       Date:  1978-05-31       Impact factor: 3.017

2.  Histological features of "pagetoid reticulosis" (Woringer-Kolopp) in pre-mycosis fungoides.

Authors:  E Haneke; A H Tulusan; F Weidner
Journal:  Arch Dermatol Res       Date:  1977-05-27       Impact factor: 3.017

3.  Sézary T-cell activating factor is a Chlamydia pneumoniae-associated protein.

Authors:  J T Abrams; E C Vonderheid; S Kolbe; D M Appelt; E J Arking; B J Balin
Journal:  Clin Diagn Lab Immunol       Date:  1999-11

4.  Ultrastructural morphometric analysis of normal human lymphocytes stimulated in vitro with mitogens and antigens.

Authors:  C M Payne; M J Hicks; A Kim
Journal:  Am J Pathol       Date:  1985-08       Impact factor: 4.307

5.  Epidermal expression of HLA-DR antigens in mycosis fungoides.

Authors:  U M Tjernlund
Journal:  Arch Dermatol Res       Date:  1978-02-15       Impact factor: 3.017

6.  Mycosis fungoides associated with Mediterranean lymphoma.

Authors:  J P Cassuto; P M Kövary; J P Campagni; J Simony; R Maiolini; M Schneider
Journal:  Arch Dermatol Res       Date:  1981       Impact factor: 3.017

7.  Lymphomatoid papulosis and Hodgkin's disease: are they related?

Authors:  R Willemze; E Scheffer; W A Van Vloten; C J Meijer
Journal:  Arch Dermatol Res       Date:  1983       Impact factor: 3.017

8.  The immunological profile of mycosis fungoides.

Authors:  J R Jensen; K Thestrup-Pedersen; S Ahrons; H Zachariae
Journal:  Clin Exp Immunol       Date:  1982-11       Impact factor: 4.330

9.  Dysregulated synthesis of intracellular type 1 and type 2 cytokines by T cells of patients with cutaneous T-cell lymphoma.

Authors:  B N Lee; M Duvic; C K Tang; C Bueso-Ramos; Z Estrov; J M Reuben
Journal:  Clin Diagn Lab Immunol       Date:  1999-01

10.  Update on the treatment of cutaneous T-cell lymphoma (CTCL): Focus on vorinostat.

Authors:  Madeleine Duvic; Jenny Vu
Journal:  Biologics       Date:  2007-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.